Venous thromboembolism associated with long-term use of central venous catheters in cancer patients;Thromboses sur cathéter central chez le patient cancéreux

Revue de Medecine Interne

Volumn 28, Issue 7, 2007, Pages 471-483

  Debourdeau, P ^a   Zammit, C ^a   Pavic, M ^a   Bensaid, B ^a   Farge Bancel, D ^b  

^a HIA Desgenettes   (France)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

Cancer; Central catheter; Prophylaxis; Venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

CANCER; CANCER CHEMOTHERAPY; CENTRAL VENOUS CATHETER; CENTRAL VENOUS CATHETERIZATION; COLOR ULTRASOUND FLOWMETRY; DEEP VEIN THROMBOSIS; DISTAL PARESTHESIA; ECHOGRAPHY; FEMALE; HEADACHE; HEALTH CARE COST; HOSPITALIZATION; HUMAN; IMAGING; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PAIN; PHLEBOGRAPHY; RISK FACTOR; SHORT SURVEY; VENOUS CONGESTION; VENOUS THROMBOEMBOLISM; EQUIPMENT DESIGN; INSTRUMENTATION; METHODOLOGY; NEOPLASM; REVIEW; THROMBOEMBOLISM;

CATHETERIZATION, CENTRAL VENOUS; EQUIPMENT DESIGN; FEMALE; HUMANS; MALE; NEOPLASMS; THROMBOEMBOLISM;

EID: 34250696571     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2007.03.002     Document Type: Short Survey

References (86)

1. Levitan N., Dowlati A., Remick S.C., Tahsildar H.I., Sivinski L.D., Beyth R., et al. Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data. Medicine (Baltimore) 78 (1999) 285-291
2. Sallah S., Wan J.Y., and Nguyen N.P. Venous thrombosis in patients with solid tumors: determination of frequency and characteristics. Thromb. Haemost. 87 (2002) 575-579
3. Goodacre S., Sutton A.J., and Sampson F.C. Meta-analysis: the value of clinical assessment in the diagnosis of deep venous thrombosis. Ann. Intern. Med. 143 (2005) 129-139
4. Heit J.A., Silverstein M.D., Mohr D.N., Petterson T.M., O'Fallon W.M., and Melton III L.J. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch. Intern. Med. 160 (2000) 809-815
5. Galloway S., and Bodenham A. Long-term central venous access. Br. J. Anaesth. 92 (2004) 722-734
6. Joffe H.V., Kucher N., Tapson V.F., and Goldhaber S.Z. Upper-extremity deep vein thrombosis: a prospective registry of 592 patients. Circulation 110 (2004) 1605-1611
7. Kuter D.J. Thrombotic complications of central venous catheters in cancer patients. Oncologist 9 (2004) 207-216
8. Hirsh J., Fuster V., Ansell J., and Halperin J.L. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. J. Am. Coll. Cardiol. 41 (2003) 1633-1652
9. Geerts W.H., Pineo G.F., Heit J.A., Bergqvist D., Lassen M.R., Colwell C.W., et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on antithrombotic and thrombolytic therapy. Chest 126 (2004) 338S-400S
10. De Cicco M., Matovic M., Balestreri L., Panarello G., Fantin D., Morassut S., et al. Central venous thrombosis: an early and frequent complication in cancer patients bearing long-term silastic catheter. A prospective study. Thromb. Res. 86 (1997) 101-113
11. Broviac J.W., Cole J.J., and Scribner B.H. A silicone rubber atrial catheter for prolonged parenteral alimentation. Surg. Gynecol. Obstet. 136 (1973) 602-606
12. Hickman R.O., Buckner C.D., Clift R.A., Sanders J.E., Stewart P., and Thomas E.D. A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg. Gynecol. Obstet. 148 (1979) 871-875
13. de Cicco M., Panarello G., Chiaradia V., Fracasso A., Veronesi A., Testa V., et al. Source and route of microbial colonisation of parenteral nutrition catheters. Lancet 2 (1989) 1258-1261
14. Keohane P.P., Jones B.J., Attrill H., Cribb A., Northover J., Frost P., et al. Effect of catheter tunnelling and a nutrition nurse on catheter sepsis during parenteral nutrition. A controlled trial. Lancet 2 (1983) 1388-1390
15. Hoffer E.K., Borsa J., Santulli P., Bloch R., and Fontaine A.B. Prospective randomized comparison of valved versus nonvalved peripherally inserted central vein catheters. Am. J. Roentgenol. 173 (1999) 1393-1398
16. Ragasa J., Shah N., and Watson R.C. Where antecubital catheters go: a study under fluoroscopic control. Anesthesiology 71 3 (1989) 378-380
17. Verdino R.J., Pacifico D.S., and Tracy C.M. Supraventricular tachycardia precipitated by a peripherally inserted central catheter. J. Electrocardiol. 29 (1996) 69-72
18. Puel V., Caudry M., Le Metayer P., Baste J.C., Midy D., Marsault C., et al. Superior vena cava thrombosis related to catheter malposition in cancer chemotherapy given through implanted ports. Cancer 72 (1993) 2248-2252
19. Mansfield P.F., Hohn D.C., Fornage B.D., Gregurich M.A., and Ota D.M. Complications and failures of subclavian-vein catheterization. N. Engl. J. Med. 331 (1994) 1735-1738
20. Verso M., and Agnelli G. Venous thromboembolism associated with long-term use of central venous catheters in cancer patients. J. Clin. Oncol. 21 (2003) 3665-3675
21. Brismar B., Hardstedt C., and Jacobson S. Diagnosis of thrombosis by catheter phlebography after prolonged central venous catheterization. Ann. Surg. 194 (1981) 779-783
22. Bernard R.W., and Stahl W.M. Subclavian vein catheterizations: a prospective study. I. Non-infectious complications. Ann. Surg. 173 (1971) 184-190
23. Gould J.R., Carloss H.W., and Skinner W.L. Groshong catheter-associated subclavian venous thrombosis. Am. J. Med. 95 (1993) 419-423
24. Morazin F., Kriegel I., Asselain B., and Falcou M.C. Symptomatic thrombosis in central venous catheter in oncology: a predictive score?. Rev. Med. Intern. 26 (2005) 273-279
25. Monreal M., Lafoz E., Ruiz J., Valls R., and Alastrue A. Upper-extremity deep venous thrombosis and pulmonary embolism. A prospective study. Chest 99 (1991) 280-283
26. Prandoni P., Polistena P., Bernardi E., Cogo A., Casara D., Verlato F., et al. Upper-extremity deep vein thrombosis. Risk factors, diagnosis, and complications. Arch. Intern. Med. 157 (1997) 57-62
27. Reed W.P., Newman K.A., Tenney J.H., and Schimpff S.C. Autopsy findings after prolonged catheterization of the right atrium for chemotherapy in acute leukemia. Surg. Gynecol. Obstet. 160 (1985) 417-420
28. oDHOS/F3/F1/2005/103 du 23 février 2005 relative à la campagne tarifaire 2005 pour les activités de médecine, chirurgie, obstétrique et odontologie exercées dans les établissements de santé privés mentionnés aux d) et e) de l'article L.162-22-6 du code de la sécurité sociale.
29. Nightingale C.E., Norman A., Cunningham D., Young J., Webb A., and Filshie J. A prospective analysis of 949 long-term central venous access catheters for ambulatory chemotherapy in patients with gastrointestinal malignancy. Eur. J. Cancer 33 (1997) 398-403
30. Borow M., and Crowley J.G. Prevention of thrombosis of central venous catheters. J. Cardiovasc. Surg. (Torino) 27 (1986) 571-574
31. Eastridge B.J., and Lefor A.T. Complications of indwelling venous access devices in cancer patients. J. Clin. Oncol. 13 (1995) 233-238
32. Biffi R., De Braud F., Orsi F., Pozzi S., Arnaldi P., Goldhirsch A., et al. A randomized, prospective trial of central venous ports connected to standard open-ended or Groshong catheters in adult oncology patients. Cancer 92 (2001) 1204-1212
33. Luciani A., Clement O., Halimi P., Goudot D., Portier F., Bassot V., et al. Catheter-related upper extremity deep venous thrombosis in cancer patients: a prospective study based on Doppler US. Radiology 220 (2001) 655-660
34. Kearns P.J., Coleman S., and Wehner J.H. Complications of long arm-catheters: a randomized trial of central vs peripheral tip location. J. Parenter. Enteral Nutr. 20 (1996) 20-24
35. Ruesch S., Walder B., and Tramer M.R. Complications of central venous catheters: internal jugular versus subclavian access: a systematic review. Crit. Care Med. 30 (2002) 454-460
36. Denys B.G., Uretsky B.F., and Reddy P.S. Ultrasound-assisted cannulation of the internal jugular vein. A prospective comparison to the external landmark-guided technique. Circulation 87 (1993) 1557-1562
37. Kraybill W.G., and Allen B.T. Preoperative duplex venous imaging in the assessment of patients with venous access. J. Surg. Oncol. 52 (1993) 244-248
38. Raad I.I., Luna M., Khalil S.A., Costerton J.W., Lam C., and Bodey G.P. The relationship between the thrombotic and infectious complications of central venous catheters. JAMA 271 (1994) 1014-1016
39. Francis C.W., Felcher A.H., White J., Braaten J.V., and Goss R. Thrombin activity associated with indwelling central venous catheters. Thromb. Haemost. 77 (1997) 48-52
40. Haire W.D., Lieberman R.P., Edney J., Vaughan W.P., Kessinger A., Armitage J.O., et al. Hickman catheter-induced thoracic vein thrombosis. Frequency and long-term sequelae in patients receiving high-dose chemotherapy and marrow transplantation. Cancer 66 (1990) 900-908
41. De Cicco M., Matovic M., Balestreri L., De Angelis V., Fracasso A., Morassut S., et al. Antithrombin III deficiency as a risk factor for catheter-related central vein thrombosis in cancer patients. Thromb. Res. 78 (1995) 127-137
42. Riordan M., and Weiden P.L. Factor V Leiden mutation does not account for central venous catheter-related thrombosis. Am. J. Hematol. 58 (1998) 150-152
43. Wermes C., von Depka Prondzinski M., Lichtinghagen R., Barthels M., Welte K., and Sykora K.W. Clinical relevance of genetic risk factors for thrombosis in paediatric oncology patients with central venous catheters. Eur. J. Pediatr. 158 (1999) S143-S146
44. Fijnheer R., Paijmans B., Verdonck L.F., Nieuwenhuis H.K., Roest M., and Dekker A.W. Factor V Leiden in central venous catheter-associated thrombosis. Br. J. Haematol. 118 (2002) 267-270
45. Mandala M., Curigliano G., Bucciarelli P., Ferretti G., Mannucci P.M., Colleoni M., et al. Factor V Leiden and G20210A prothrombin mutation and the risk of subclavian vein thrombosis in patients with breast cancer and a central venous catheter. Ann. Oncol. 15 (2004) 590-593
46. Jansen F.H., van der Straaten H.M., Roest M., Haas F., de Groot P.G., and Fijnheer R. Elevated levels of D-dimer and fragment 1+2 upon central venous catheter insertion and factor V Leiden predict subclavian vein thrombosis. Haematologica 90 (2005) 499-504
47. Van Rooden C.J., Rosendaal F.R., Meinders A.E., Van Oostayen J.A., Van Der Meer F.J., and Huisman M.V. The contribution of factor V Leiden and prothrombin G20210A mutation to the risk of central venous catheter-related thrombosis. Haematologica 89 (2004) 201-206
48. Tolar B., and Gould J.R. The prognostic significance of the ball-valve effect in Groshong catheters. Support. Care Cancer 4 (1996) 34-38
49. Baarslag H.J., van Beek E.J., Koopman M.M., and Reekers J.A. Prospective study of color duplex ultrasonography compared with contrast venography in patients suspected of having deep venous thrombosis of the upper extremities. Ann. Intern. Med. 136 (2002) 865-872
50. Anaes. Guide du bon usage des examens d'imagerie médicale (2005) (44)
51. Falk R.L., and Smith D.F. Thrombosis of upper extremity thoracic inlet veins: diagnosis with duplex Doppler sonography. Am. J. Roentgenol. 149 (1987) 677-682
52. Knudson G.J., Wiedmeyer D.A., Erickson S.J., Foley W.D., Lawson T.L., Mewissen M.W., et al. Color Doppler sonographic imaging in the assessment of upper-extremity deep venous thrombosis. Am. J. Roentgenol. 154 (1990) 399-403
53. Hubsch P.J., Stiglbauer R.L., Schwaighofer B.W., Kainberger F.M., and Barton P.P. Internal jugular and subclavian vein thrombosis caused by central venous catheters. Evaluation using Doppler blood flow imaging. J. Ultrasound Med. 7 (1988) 629-636
54. Haire W.D., Lynch T.G., Lund G.B., Lieberman R.P., and Edney J.A. Limitations of magnetic resonance imaging and ultrasound-directed (duplex) scanning in the diagnosis of subclavian vein thrombosis. J. Vasc. Surg. 13 (1991) 391-397
55. Baxter G.M., Kincaid W., Jeffrey R.F., Millar G.M., Porteous C., and Morley P. Comparison of colour Doppler ultrasound with venography in the diagnosis of axillary and subclavian vein thrombosis. Br. J. Radiol. 64 (1991) 777-781
56. Koksoy C., Kuzu A., Kutlay J., Erden I., Ozcan H., and Ergin K. The diagnostic value of colour Doppler ultrasound in central venous catheter related thrombosis. Clin. Radiol. 50 (1995) 687-689
57. Patel M.C., Berman L.H., Moss H.A., and McPherson S.J. Subclavian and internal jugular veins at Doppler US: abnormal cardiac pulsatility and respiratory phasicity as a predictor of complete central occlusion. Radiology 211 (1999) 579-583
58. Sottiurai V.S., Towner K., McDonnell A.E., and Zarins C.K. Diagnosis of upper extremity deep venous thrombosis using non-invasive technique. Surgery 91 (1982) 582-585
59. Mustafa B.O., Rathbun S.W., Whitsett T.L., and Raskob G.E. Sensitivity and specificity of ultrasonography in the diagnosis of upper extremity deep vein thrombosis: a systematic review. Arch. Intern. Med. 162 (2002) 401-404
60. Forneris G., Quarello F., Pozzato M., and Vaudano G.P. Spiral x-ray computed tomography in the diagnosis of central venous catheterization complications. Nephrologie 22 (2001) 495-499
61. Hartnell G.G., Hughes L.A., Finn J.P., and Longmaid III H.E. Magnetic resonance angiography of the central chest veins. A new gold standard?. Chest 107 (1995) 1053-1057
62. Rose S.C., Gomes A.S., and Yoon H.C. MR angiography for mapping potential central venous access sites in patients with advanced venous occlusive disease. Am. J. Roentgenol. 166 (1996) 1181-1187
63. Shankar K.R., Abernethy L.J., Das K.S., Roche C.J., Pizer B.L., Lloyd D.A., et al. Magnetic resonance venography in assessing venous patency after multiple venous catheters. J. Pediatr. Surg. 37 (2002) 175-179
64. Male C., Chait P., Ginsberg J.S., Hanna K., Andrew M., Halton J., et al. Comparison of venography and ultrasound for the diagnosis of asymptomatic deep vein thrombosis in the upper body in children: results of the PARKAA study. Prophylactic Antithrombin Replacement in Kids with ALL treated with Asparaginase. Thromb. Haemost. 87 (2002) 593-598
65. Haire W.D., Lynch T.G., Lieberman R.P., Lund G.B., and Edney J.A. Utility of duplex ultrasound in the diagnosis of asymptomatic catheter-induced subclavian vein thrombosis. J. Ultrasound Med. 10 (1991) 493-496
66. van Rooden C.J., Rosendaal F.R., Barge R.M., van Oostayen J.A., van der Meer F.J., Meinders A.E., et al. Central venous catheter related thrombosis in haematology patients and prediction of risk by screening with Doppler-ultrasound. Br. J. Haematol. 123 (2003) 507-512
67. Buller H.R., Agnelli G., Hull R.D., Hyers T.M., Prins M.H., and Raskob G.E. Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on antithrombotic and thrombolytic therapy. Chest 126 (2004) 401S-428S
68. Savage K.J., Wells P.S., Schulz V., Goudie D., Morrow B., Cruickshank M., et al. Outpatient use of low molecular weight heparin (Dalteparin) for the treatment of deep vein thrombosis of the upper extremity. Thromb. Haemost. 82 (1999) 1008-1010
69. Lee A.Y., Levine M.N., Baker R.I., Bowden C., Kakkar A.K., Prins M., et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N. Engl. J. Med. 349 (2003) 146-153
70. Meyer G., Marjanovic Z., Valcke J., Lorcerie B., Gruel Y., Solal-Celigny P., et al. Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study. Arch. Intern. Med. 162 (2002) 1729-1735
71. Stephens L.C., Haire W.D., Tarantolo S., Reed E., Schmit-Pokorny K., Kessinger A., et al. Normal saline versus heparin flush for maintaining central venous catheter patency during apheresis collection of peripheral blood stem cells (PBSC). Transfus. Sci. 18 (1997) 187-193
72. Clemence M.A., Walker D., and Farr B.M. Central venous catheter practices: results of a survey. Am. J. Infect. Control 23 (1995) 5-12
73. Bern M.M., Lokich J.J., Wallach S.R., Bothe Jr. A., Benotti P.N., Arkin C.F., et al. Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial. Ann. Intern. Med. 112 (1990) 423-428
74. Boraks P., Seale J., Price J., Bass G., Ethell M., Keeling D., et al. Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with haematological malignancies. Br. J. Haematol. 101 (1998) 483-486
75. Carr K.M., and Rabinowitz I. Physician compliance with warfarin prophylaxis for central venous catheters in patients with solid tumors. J. Clin. Oncol. 18 (2000) 3665-3667
76. Minassian V.A., Sood A.K., Lowe P., Sorosky J.I., Al-Jurf A.S., and Buller R.E. Long-term central venous access in gynecologic cancer patients. J. Am. Coll. Surg. 19 (2000) 403-409
77. Monreal M., Alastrue A., Rull M., Mira X., Muxart J., Rosell R., et al. Upper extremity deep venous thrombosis in cancer patients with venous access devices: prophylaxis with a low molecular weight heparin (Fragmin). Thromb. Haemost. 75 (1996) 251-253
78. Pucheu A., Leduc B., Sillet-Bach I., Payen C., Assaf W., and Pucheu M. Experimental prevention of deep venous thrombosis with low-molecular-weight heparin using implantable infusion devices. Ann. Cardiol. Angeiol. (Paris) 45 (1996) 59-63
79. Couban S., Goodyear M., Burnell M., Dolan S., Wasi P., Barnes D., et al. Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer. J. Clin. Oncol. 23 (2005) 4063-4069
80. Verso M., Agnelli G., Bertoglio S., Di Somma F.C., Paoletti F., Ageno W., et al. Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients. J. Clin. Oncol. 23 (2005) 4057-4062
81. Massicotte P., Julian J.A., Gent M., Shields K., Marzinotto V., Szechtman B., et al. An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial. Thromb. Res. 109 (2003) 101-108
82. Karthaus M., Kretzschmar A., Kroning H., Biakhov M., Irwin D., Marschner N., et al. Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial. Ann. Oncol. 17 (2006) 289-296
83. Mismetti P., Mille D., Laporte S., Charlet V., Buchmuller-Cordier A., Jacquin J.P., et al. Low-molecular-weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: a pilot randomized trial. Haematologica 88 (2003) 67-73
84. Randolph A.G., Cook D.J., Gonzales C.A., and Andrew M. Benefit of heparin in central venous and pulmonary artery catheters: a meta-analysis of randomized controlled trials. Chest 113 (1998) 165-171
85. Masci G., Magagnoli M., Zucali P.A., Castagna L., Carnaghi C., Sarina B., et al. Minidose warfarin prophylaxis for catheter-associated thrombosis in cancer patients: can it be safely associated with fluorouracil-based chemotherapy?. J. Clin. Oncol. 21 (2003) 736-739
86. Magagnoli M., Masci G., Carnaghi C., Zucali P.A., Castagna L., Morenghi E., et al. Minidose warfarin is associated with a high incidence of International Normalized Ratio elevation during chemotherapy with FOLFOX regimen. Ann. Oncol. 14 (2003) 959-960